Exploration of selected monoterpenes as potential TRPC channel family modulator in lung cancer, an in-silico upshot

Abstract excerpt

Lung cancer is still the most frequent cause of cancer-related death, accounting for nearly two million cases yearly. As cancer is a multifactorial disease, developing novel molecular therapeutics that can simultaneously target multiple associated cellular processes has become necessary. Ion channels are diverse regulators of cancer-related processes such as abnormal proliferation, invasion, migration, tumor...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bioactive Compounds and Antitumor Agents
• Share to Herbal Medicine Research Studies
• Share to Ion Channels and Receptors